Company: ENTXW
Filing Date: 2025-05-30
Form Type: S-3
Source: 0001178913-25-002025
Chunk: 20

Company: Entera Bio Ltd.
Filing Date: 2025-05-30
Form: S-3
Chunk 20
---
 we offer will include specific terms relating to the offering, the terms of the warrants and any applicable warrant agreements. These terms will include some or all of the following:

| • | the title of the warrants; |

| • | the aggregate number of warrants offered; |

| • | the designation, number and terms of the ordinary shares, debt securities, or other securities purchasable upon exercise of the warrants and procedures by which those numbers may be adjusted; |

| • | the exercise price of the warrants; |

| • | the dates or periods during which the warrants are exercisable; |

| • | the designation and terms of any securities with which the warrants are issued; |

| • | if the warrants are issued as a unit with another security, the date on and after which the warrants and the other security will be separately transferable; |

| • | if the exercise price is not payable in U.S. dollars, the foreign currency, currency unit or composite currency in which the exercise price is denominated; |

| • | any minimum or maximum amount of warrants that may be exercised at any one time; |

| • | any terms relating to the modification of the warrants; |

| • | if applicable, a discussion of the material Israeli and U.S. income tax considerations applicable to the issuance or exercise of such warrants; |

| • | the anti-dilution and adjustment of share capital provisions of the warrants, if any; |

| • | any circumstances that will cause the warrants to be deemed to be automatically exercised; and |

| • | any terms, procedures and limitations relating to the transferability, exchange or exercise of the warrants; and |

| • | any other specific terms of the warrants. |

14 DESCRIPTION OF RIGHTS We may issue rights to purchase any of our securities or any combination thereof. Rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the rights. The rights may be issued independently or together with any other security offered hereby and may or may not be transferable by the shareholder receiving the subscription rights in such offering. In connection with any rights offering to our shareholders, we may enter into a standby underwriting arrangement with one or more underwriters pursuant to which such underwriters will purchase any offered securities remaining unsubscribed for after such rights offering. We may also appoint a rights agent that may act solely as our agent in connection with the rights that are sold. Any such agent will not assume any obligation or relationship of agency or trust